Home

Jeremy M. Levin, CEO: Ovid Therapeutics OVID Buy · Filed 24/03/20

Trade details

Type
Insider buy
Amount
$50,364.48
Shares · price
18,248 sh · $2.76 a share
Held after
3,616,715 sh
Trade date
24/03/18
Filed
24/03/20
Days to filing
2 days

First buy since 2023

Insiders buying this week
1 insiders
Holding change
+0.5%

Ovid Therapeutics trades, last 26 weeks

What else happened in Ovid Therapeutics around then

Filed or reported within 30 days of the trade day · 24/02/17~24/04/17

Jeremy M. Levin's recent trades

No other trades yet.